Christoph Brackmann - 03 Mar 2026 Form 4 Insider Report for NovoCure Ltd (NVCR)

Role: Chief Financial Officer
Signature: Steven Robbins, as attorney in fact for Brackmann, Christoph
Issuer symbol: NVCR
Transactions as of: 03 Mar 2026
Net transactions value: -$85,314
Form type: 4
Filing time: 05 Mar 2026, 16:31:55 UTC
Previous filing: 04 Nov 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Brackmann Christoph	Chief Financial Officer	C/O NOVOCURE INC., 1550 LIBERTY RIDGE DRIVE, SUITE 115, WAYNE	Steven Robbins, as attorney in fact for Brackmann, Christoph	05 Mar 2026	0002048634

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	NVCR	Ordinary Shares	Award		+55,137	+41%	$0.000000^*	189,254	03 Mar 2026	Direct	F1
transaction	NVCR	Ordinary Shares	Sale	$85,314	-6,412	-3.4%	$13.31	182,842	04 Mar 2026	Direct	F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	NVCR	Stock Option (Right to Buy)	Award		+80,674		$0.000000^*	80,674	03 Mar 2026	Ordinary Shares	80,674	$13.30	Direct	F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents restricted share units that are scheduled to vest in equal parts on the first, second and third anniversary of the grant date, subject to the reporting person's continued employment through such dates.
F2	Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
F3	This transaction was executed in multiple trades at prices ranging from $13.21 USD to $13.445 USD; the price reported above reflects the weighted average sale price.
F4	Options to buy ordinary shares that are scheduled to vest in equal parts on the first, second, third and fourth anniversary of the grant date, subject to the reporting person's continued employment through such date.